Details for Patent: 8,399,514
✉ Email this page to a colleague
Which drugs does patent 8,399,514 protect, and when does it expire?
Patent 8,399,514 protects TECFIDERA and is included in one NDA.
This patent has forty-one patent family members in eighteen countries.
Summary for Patent: 8,399,514
| Title: | Treatment for multiple sclerosis |
| Abstract: | Provided are certain methods of screening, identifying, and evaluating neuroprotective compounds useful for treatment of neurological diseases, such as, e.g., multiple sclerosis (MS). The compounds described upregulate the cellular cytoprotective pathway regulated by Nrf2. Also provided are certain methods of utilizing such compounds in therapy for neurological disease, particularly, for slowing or reducing demyelination, axonal loss, or neuronal and oligodendrocyte death. |
| Inventor(s): | Lukashev; Matvey E. (Tewksbury, MA), O'Neill; Gilmore (Medford, MA) |
| Assignee: | Biogen Idec MA Inc. (Cambridge, MA) |
| Application Number: | 13/372,426 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,399,514 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Dosage form; |
Drugs Protected by US Patent 8,399,514
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biogen Inc | TECFIDERA | dimethyl fumarate | CAPSULE, DELAYED RELEASE;ORAL | 204063-001 | Mar 27, 2013 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | METHOD OF TREATING MULTIPLE SCLEROSIS | ⤷ Sign Up | |||
| Biogen Inc | TECFIDERA | dimethyl fumarate | CAPSULE, DELAYED RELEASE;ORAL | 204063-002 | Mar 27, 2013 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | METHOD OF TREATING MULTIPLE SCLEROSIS | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,399,514
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2137537 | ⤷ Sign Up | C300674 | Netherlands | ⤷ Sign Up |
| European Patent Office | 2137537 | ⤷ Sign Up | CA 2014 00035 | Denmark | ⤷ Sign Up |
| European Patent Office | 2137537 | ⤷ Sign Up | PA2014024 | Lithuania | ⤷ Sign Up |
| European Patent Office | 2137537 | ⤷ Sign Up | 1490038-5 | Sweden | ⤷ Sign Up |
| European Patent Office | 2137537 | ⤷ Sign Up | 92487 | Luxembourg | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
